血液学中的治疗抗体:恶性和非恶性疾病的进展
Hiroshi Yasui1,2, Masashi Idogawa3, Tadao Ishida4
1Department of Hematology and Oncology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Cells
|January 9, 2026
概括
治疗性抗体正在改变血液学,改善血液癌症和非恶性疾病如血友病A的治疗结果. 对抗体格式和标的创新为患者提供了更高的疗效和安全性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 治疗性抗体已经显著提升了血液学,为各种血液疾病提供了向治疗.
- 主要目标包括在血液恶性瘤中的CD20,CD19,CD38和B细胞成熟抗原 (BCMA).
- 非恶性疾病,如阳性夜间血红蛋白尿和血友病A也受益于抗体疗法.
研究的目的:
- 审查血液学疾病治疗抗体的最新进展.
- 总结这些基于抗体的新型治疗方法的作用机制.
- 讨论改善抗体疗法的有效性和安全性的新兴策略.
主要方法:
- 关于血液学治疗抗体的关键进展的文献综述.
- 对抗体作用机制的分析,包括抗体与药物合物,双特异性抗体和补充抑制剂.
- 检查新型抗体格式和T细胞重定向设计.
主要成果:
- 使用针对CD20,CD19,CD38和BCMA的抗体,对血液性恶性瘤的生存结果显著改善.
- 通过补充抑制剂重新定义了帕洛西斯马夜间血红蛋白尿和非典型的血清性尿素综合征的治疗方法.
- 在A型血友病中用双特异抗体艾米齐祖马布进行转化预防.
- 像三功能抗CD38 × CD3抗体这样的新型形式显示出增强的抗髓瘤活性.
结论:
- 治疗性抗体彻底改变了血液学,为恶性和非恶性血液疾病提供了有效的治疗方法.
- 对抗体格式和向策略的持续创新有望进一步改善患者护理.
- 未来的研究方向包括通过先进的抗体设计优化疗效和安全性.
更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.8K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
8.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Bone Marrow Sampling and Transplants
862
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
862
Hybridoma Technology
17.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.2K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
